Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant ASCENT: A Phase II Trial of Induction, Consolidation and Maintenance in Subjects with High Risk Smoldering Multiple Myeloma SMM

Brief Summary

Type:
Multiple Myeloma

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03289299

Study #:
STUDY00142568

Start Date:
Aug 21, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03289299

View Complete Trial Details & Eligibility at ClinicalTrials.gov